HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tailored Trojan horse nanocarriers for enhanced redox-responsive drug delivery.

Abstract
Redox-responsive anti-tumor nanomedicine is appealing in improving the therapeutic efficacy and patient compliance. However, the thiol-disulfide exchange reaction is reversible and kinetically very slow, resulting in poor drug release and delayed onset of drug action. To address this issue, a tailored Trojan horse nanocarrier is designed with pH-labile zeolitic imidazolate framework-8 (ZIF-8) as the core and disulfide-linked amphiphilic polymer-drug conjugate as the steric shell. A potent reductant, tris(3-hydroxypropyl)phosphine (THPP) is loaded in ZIF-8 and capped by myristyl alcohol. At low pH (e.g. endosome and lysosome), the collapse of ZIF-8 can induce the liberation of THPP that further cleaves the disulfide bond and release the drug post self-immolation. As the reaction between THPP and disulfide is both thermodynamically and kinetically favored, the drug release rate can be boosted. The proof-of-concept is demonstrated both in 4T1 murine mammary carcinoma cells and 4T1 tumor-bearing mice with curcumin as the model drug. Compared to the control nanosystem without THPP, the tailored nanocarrier can significantly enhance the drug release and hence therapeutic efficacy, which is demonstrated by the assays of cell viability, tumor growth inhibition, and histological staining. Such strategy can extend to a plethora of thiol-free cargos for controlled intracellular delivery.
AuthorsYaru Li, Simin Feng, Peipei Dai, Fang Liu, Yaqi Shang, Qian Yang, Juan Qin, Zhiguang Yuchi, Zheng Wang, Yanjun Zhao
JournalJournal of controlled release : official journal of the Controlled Release Society (J Control Release) Vol. 342 Pg. 201-209 (02 2022) ISSN: 1873-4995 [Electronic] Netherlands
PMID34998915 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2022. Published by Elsevier B.V.
Chemical References
  • Drug Carriers
  • Doxorubicin
Topics
  • Animals
  • Doxorubicin (chemistry)
  • Drug Carriers (chemistry)
  • Drug Delivery Systems (methods)
  • Drug Liberation
  • Humans
  • Mice
  • Nanoparticles (chemistry)
  • Oxidation-Reduction

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: